Amylx Pharmaceuticals Inc vs TeraWulf Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while TeraWulf Inc trades at $17.77 (market cap $8.35B). The key difference: TeraWulf Inc is far larger — about 3.2× Amylx Pharmaceuticals Inc's market cap, and Amylx Pharmaceuticals Inc is trading nearer its 52-week high, TeraWulf Inc nearer its low. Which is the better fit depends on your goals.
| AMLX | WULF | |
|---|---|---|
Market Cap | $2.64B | $8.35B |
Sector | Health | Technology |
52-Week High | $24.19 | $28.98 |
52-Week Low | $7.82 | $5.24 |
Enterprise Value | $2.39B | $10.97B |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →TeraWulf develops, owns, and operates fully integrated digital infrastructure powered by predominantly zero-carbon energy. It utilizes a hybrid business model that combines industrial-scale Bitcoin mining with high-performance computing (HPC) and AI hosting, leveraging sustainable power sources like nuclear and hydroelectric to deliver low-cost, energy-efficient data center solutions.
Read more on WULF →